Welcome to Chapter 4.2: Immunity!
Welcome to one of the most exciting and vital topics in your CCEA A2 1 Biology specification. In this chapter, we explore how your body acts like a fortress to protect you against disease-causing microorganisms (pathogens). We will look at your body's physical and chemical defence systems, the specialised world of white blood cells, antibodies, vaccines, blood groups, and modern medical technologies like monoclonal antibodies.
Don't worry if this seems tricky or overwhelming at first! We will break every process down step-by-step with clear analogies, mnemonics, and practical exam tips so that you can tackle any question on Paper ABY11 with confidence.
---1. Non-Specific vs. Specific Defences
Your immune system is split into two main defence tiers: non-specific defences (which treat all invaders the same) and specific defences (which create custom-made targeted weapons against particular pathogens).
A. Non-Specific Defences (The Physical and Chemical Fortress)
These primary and secondary barriers operate continuously against all foreign invaders, regardless of their species:
• Keratinised Skin: An intact, waterproof outer barrier that physically prevents microorganisms from entering the body.
• Mucous Membranes: Line the respiratory, digestive, and reproductive tracts. Mucus traps dust and microbes, which are then swept away by cilia or swallowed.
• Stomach Acid (Hydrochloric Acid): Provides a very low pH environment that denatures pathogen enzymes and destroys them before they can enter the intestines.
• Lysozymes: Antibacterial enzymes found in secretions like tears and sweat that hydrolyse bacterial cell walls (specifically targeting peptidoglycan).
B. Phagocytosis (The Clean-up Crew)
When a pathogen breaks through your physical barriers, non-specific white blood cells—mainly neutrophils and macrophages—spring into action through a process called phagocytosis.
Step-by-Step Mechanism of Phagocytosis:
1. Attraction and Endocytosis: Phagocytes move toward the pathogen and engulf it via endocytosis.
2. Phagosome Formation: The pathogen is enclosed within an intracellular membrane-bound vesicle called a phagosome.
3. Fusion: Lysosomes inside the phagocyte fuse with the phagosome to form a phagolysosome.
4. Digestion: Lysosomes release hydrolytic enzymes (such as lysozyme and proteases) into the phagolysosome, which digest and break down the pathogen.
5. Antigen Presentation: Macrophages do not simply discard the debris; they process the pathogen's molecules and display them on their cell surface bound to MHC (Major Histocompatibility Complex) markers. This turns the macrophage into an Antigen-Presenting Cell (APC), linking the non-specific defence directly to the specific immune response!
Analogy: Think of a macrophage like a security guard that captures an intruder, breaks them down, and then sticks the intruder's photo onto a noticeboard (the MHC marker) so the specialized detective team (T-cells) knows who to look for!
Key Takeaway: Non-specific defences act immediately against any invader using physical barriers, chemical secretions, and phagocytic cells. Macrophages link non-specific defences to specific defences by becoming Antigen-Presenting Cells (APCs).
---2. The Specific Immune Response & Antibodies
A. Antigens and Antibodies
• Antigen: A macromolecule (usually a protein or glycoprotein) foreign to the host organism that stimulates a specific immune response.
• Antibody (Immunoglobulin): A Y-shaped globular glycoprotein produced and secreted by plasma cells in response to a specific antigen.
B. Antibody Structure
Understanding the Y-shaped structure of an antibody is essential for CCEA exams:
• Polypeptide Chains: Built from four polypeptide chains—two identical heavy chains and two identical light chains.
• Disulfide Bridges: Strong covalent disulfide bridges hold the four chains together.
• Constant Region: The lower stem of the Y-shape. It is identical within a class of antibodies and interacts with immune system receptors.
• Variable Region: The tips of the Y-shape. This region has a unique, specific 3D tertiary conformation forming antigen-binding sites that are complementary to a specific epitope on the antigen.
• Hinge Region: Provides flexibility, allowing the antibody's antigen-binding sites to bind to two separate antigens simultaneously.
C. How Antibodies Destroy Pathogens (Modes of Action)
Antibodies do not destroy pathogens by eating them; they disable them or tag them using several mechanisms:
1. Agglutination: Because each antibody has at least two antigen-binding sites, they can bind to multiple pathogens at once, clumping them together. This immobilises the pathogens and makes it much easier for phagocytes to engulf them in large numbers.
2. Neutralisation: Antibodies bind directly to bacterial toxins or surface receptor proteins on viruses, physically blocking them from attaching to or invading host cells.
3. Opsonisation: Antibodies coat the surface of the pathogen, acting as chemical markers ("flags") that make it easier for phagocytes to identify and attach to them.
4. Lysis: Antibodies can trigger cellular mechanisms that puncture and rupture bacterial cell membranes.
Common Mistake to Avoid: Never confuse agglutination with blood clotting (coagulation)! Agglutination is the antibody-antigen clumping of whole cells. Blood clotting is an enzyme-driven cascade that converts soluble fibrinogen into insoluble fibrin fibres.
Key Takeaway: Antibodies are Y-shaped glycoproteins with variable antigen-binding sites complementary to specific antigens. They work by agglutination, neutralisation, opsonisation, and lysis.
---3. Cell-Mediated vs. Humoral Immunity
The specific immune response relies on two types of white blood cells known as lymphocytes:
• T-Lymphocytes (T-cells): Formed in the bone marrow, but mature in the Thymus gland. They carry out cell-mediated immunity (targeting infected host cells, foreign tissue, and intracellular pathogens).
• B-Lymphocytes (B-cells): Formed and mature in the Bone marrow. They carry out humoral immunity (producing circulating antibodies that target extracellular pathogens and toxins in body fluids/humours).
Memory Trick: T-cells mature in the Thymus; B-cells mature in the Bone marrow!
A. Cell-Mediated Immunity (T-Cells in Action)
T-cells respond only to foreign antigens that are presented on the surface of cells (e.g., APCs, virus-infected cells, cancer cells, or transplanted tissue).
1. Detection: T-Helper cells (\(T_h\)) possess specific receptors complementary to foreign antigens presented on APCs.
2. Activation & Cytokines: Once bound, \(T_h\) cells release chemical signalling molecules called cytokines (such as interleukins).
3. Proliferation & Differentiation: Cytokines stimulate T-cells to divide by mitosis into specialized subtypes:
• Cytotoxic / Killer T-cells (\(T_c\)): Release destructive proteins like perforins and toxins, punching holes in the cell membranes of infected or foreign cells to cause lysis.
• T-Memory cells (\(T_m\)): Remain long-term in the blood and lymphatic system to provide rapid future responses.
• T-Suppressor / Regulatory cells: Inhibit and shut down the immune response once the infection has been successfully cleared.
• Cytokine action on B-cells: \(T_h\) cytokines also stimulate B-lymphocytes to undergo clonal expansion!
B. Humoral Immunity (B-Cells and Antibody Production)
1. Clonal Selection: Millions of B-cells circulate in your body, each with specific membrane-bound antibodies. When a specific B-cell encounters its complementary extracellular antigen, it binds to it.
2. Clonal Expansion: Stimulated by cytokines released from activated \(T_h\) cells, the selected B-cell undergoes repeated mitosis to produce a large clone of identical cells.
3. Differentiation: The clone differentiates into two cell types:
• Plasma Cells: Short-lived cells that produce and secrete thousands of specific antibodies per second into the blood plasma and lymph.
• B-Memory Cells: Long-lived cells that remain in circulation for years. They do not secrete antibodies immediately, but divide rapidly into plasma cells if the same antigen enters the body again.
C. Primary vs. Secondary Immune Response
Primary Response (First Exposure):
• Latent Period: There is a noticeable delay (lag phase) while clonal selection, expansion, and differentiation of B- and T-cells take place.
• Antibody Output: Produces a relatively low concentration of antibodies at a slow rate.
• Result: The pathogen has time to replicate and cause tissue damage, leading to clinical symptoms of disease.
Secondary Response (Re-exposure to Same Antigen):
• Latent Period: Very short or practically non-existent because long-lived memory cells recognise the antigen almost immediately.
• Antibody Output: Antibodies are produced significantly faster, reaching a much higher peak concentration and persisting longer in the blood.
• Result: The pathogen is destroyed before it can cause noticeable cellular damage, conferring active immunity without disease symptoms!
Key Takeaway: \(T_h\) cells are the coordinators of the immune response—they release cytokines that activate killer \(T_c\) cells and stimulate B-cells to divide into antibody-producing plasma cells and long-lived memory cells.
---4. Types of Immunity & Herd Immunity
A. Classifying Immunity
Immunity can be categorized as active (the individual makes their own antibodies and memory cells) or passive (antibodies are given from an external source, so no memory cells are made):
• Active Natural: Direct infection by a live pathogen. Your body undergoes clonal selection, synthesises its own antibodies, and forms long-lasting memory cells.
• Active Artificial: Vaccination. Antigens from attenuated (weakened) pathogens, dead pathogens, toxoids (inactivated toxins), or antigen subunits are injected to trigger an immune response and generate memory cells without causing the full disease.
• Passive Natural: Transfer of maternal antibodies to the baby across the placenta or via colostrum/breast milk. Provides immediate, short-term protection. No memory cells are produced.
• Passive Artificial: Injection of pre-formed antibodies (e.g., emergency antivenom or antiserum). Provides immediate protection against deadly toxins, but is temporary because the foreign antibodies are broken down and no memory cells are formed.
Quick Summary Comparison:
• Active Immunity: Slow to develop initially, involves memory cells, provides long-term protection.
• Passive Immunity: Immediate protection, involves NO memory cells, provides only short-term protection.
B. Herd Immunity
Herd immunity occurs when a sufficiently high percentage of a population is vaccinated or immune against a pathogen. Because there are very few susceptible hosts, transmission chains are broken, which indirectly protects vulnerable, non-vaccinated individuals (e.g., very young babies or immunocompromised patients).
Key Takeaway: Active immunity produces immunological memory (long-lasting), while passive immunity provides immediate antibodies without memory (short-lived). Herd immunity protects vulnerable individuals by interrupting pathogen transmission.
---5. Clinical Applications, Transplants, Blood Groups & Antibiotics
A. Monoclonal Antibodies
Monoclonal antibodies are identical antibodies produced from a single clone of specialised cells. They are specific to one particular antigen binding site.
• Production (Hybridoma Technology): A mouse is injected with the target antigen to stimulate specific plasma cells. These plasma cells are extracted from the spleen and fused with immortal cancerous cells called myeloma cells using a fusing agent. The resulting hybrid cell is a hybridoma, which can divide indefinitely in culture while secreting huge quantities of identical, pure monoclonal antibodies.
• Applications: Used in diagnostic assays (such as pregnancy test kits and medical imaging) and targeted cancer therapies.
B. Organ Transplant Rejection
When an organ (e.g., kidney) is transplanted, the recipient's immune system recognizes the donor's Human Leukocyte Antigens (HLA / MHC) as foreign:
1. Host T-lymphocytes identify the foreign HLA markers, launching a cell-mediated immune response.
2. Cytotoxic T-cells release perforins to destroy the transplanted tissue (graft rejection).
3. Prevention:
• Tissue Typing: Matching donor and recipient HLA markers as closely as possible.
• Immunosuppressive Drugs: Administering medications (such as cyclosporin) that suppress T-cell activity, though this increases the recipient's susceptibility to other opportunistic infections.
C. ABO Blood Groups & The Rhesus System
1. The ABO System:
Red blood cells have surface antigens (Antigen A, Antigen B, both, or neither). Blood plasma contains complementary antibodies:
• Group A: Has Antigen A on red blood cells; possesses Anti-B antibodies in plasma.
• Group B: Has Antigen B on red blood cells; possesses Anti-A antibodies in plasma.
• Group AB: Has both Antigen A and Antigen B; possesses neither antibody in plasma (Universal recipient).
• Group O: Has neither antigen; possesses both Anti-A and Anti-B antibodies in plasma (Universal donor).
Danger: Transfusing incompatible blood causes recipient antibodies to bind to donor red blood cell antigens, causing life-threatening agglutination and haemolysis.
2. The Rhesus System and Pregnancy:
• People are either Rhesus positive (\(Rh^+\), possessing the Rhesus antigen) or Rhesus negative (\(Rh^-\), lacking the Rhesus antigen).
• Haemolytic Disease of the Newborn (Erythroblastosis Fetalis):
1. If an \(Rh^-\) mother carries a first \(Rh^+\) baby, fetal red blood cells may leak into the maternal circulation during birth.
2. The mother's immune system responds by producing anti-\(Rh\) antibodies and memory cells (sensitization).
3. During a subsequent pregnancy with another \(Rh^+\) fetus, the mother's memory cells produce high levels of anti-\(Rh\) antibodies. These cross the placenta, bind to the fetal red blood cells, and cause agglutination and destruction.
D. Antimicrobial Action & Antibiotic Resistance
Antibiotics are chemical compounds used to treat bacterial infections. They work via two primary modes of action:
• Bactericidal: Kills bacteria directly (e.g., penicillins, which inhibit peptidoglycan cell wall synthesis, causing bacterial lysis).
• Bacteriostatic: Inhibits bacterial growth and reproduction, allowing the host immune system to destroy them (e.g., tetracyclines, which inhibit bacterial 70S protein synthesis).
Antibiotic Resistance:
• Mechanism: Arises initially via a random spontaneous mutation in a bacterial gene. When an antibiotic is applied, it acts as an environmental selection pressure—susceptible bacteria die, while resistant mutants survive.
• Transmission: The resistant bacteria reproduce, passing the resistance gene to offspring (vertical gene transfer). They can also transfer resistance genes to other bacterial cells on small rings of DNA called plasmids (horizontal gene transfer via conjugation).
Crucial Rule for Exams: Antibiotics do NOT work on viruses! Viruses lack bacterial targets like peptidoglycan walls, 70S ribosomes, and independent metabolic pathways.
Key Takeaway: Monoclonal antibodies come from hybridoma cells. Transplants require HLA matching and immunosuppression. Antibiotics can be bactericidal or bacteriostatic, but resistance develops through random mutation followed by natural selection.
---Chapter Review & Common Pitfalls Checklist
Before sitting your exam, make sure you never make these common mistakes:
• Antigen vs. Antibody: An antigen is the foreign marker on a cell/toxin; an antibody is the Y-shaped protein made by plasma cells to bind to that antigen.
• T-Cells vs. B-Cells: T-cells do not make antibodies! Only B-derived plasma cells secrete antibodies.
• Agglutination vs. Clotting: Agglutination is antigen-antibody clumping; clotting is a fibrin enzyme cascade.
• Passive Immunity Memory: Passive immunity (e.g., maternal milk or antivenom) does not produce memory cells and gives only temporary protection.
• Antibiotics on Viruses: Antibiotics are completely ineffective against viruses.